I do not know what the market was expecting, but LMNS does not seem to be an unmitigated disaster. Revenue growth is 9.5%, they made 3.3m operating income (on a non GAAP basis excluding IPO costs), they expect 2014 EPS to be between 50 and 54 cents. For a company that is growing, has some new FDA approvals and a stock price of $9.40 - that is not terrible. I do not plan to hold this stock forever, but neither is it a hot potato.
I feel better.
In total, my portfolio was very good today, up almost 1.5%. LMNS helped, as did GNW and AVG. In fact, my newest MFI tranche is off to a respectable start (3 1/2 days in):
Start | Current | Dividend | Pct Gain | R3K Gain | |
AVG | $19.57 | $19.80 | $0.00 | 1.2% | 1.1% |
CA | $29.54 | $30.17 | $0.00 | 2.1% | 1.1% |
$22.79 | $23.19 | $0.00 | 1.8% | 1.1% | |
NSR | $25.82 | $27.40 | $0.00 | 6.1% | 1.1% |
$28.78 | $29.72 | $0.00 | 3.3% | 1.1% | |
Totals | 2.9% | 1.1% |
No comments:
Post a Comment